1. Leader in the plant-based combination therapy space.
2. First to bring plant-based Alzheimer’s medication to patients in select medical states in the U.S.
3. First to acquire patent-pending research from the University of South Florida (USF) for Alzheimer’s.
4. Anticipate medical trials for Alzheimer’s and Parkinson’s plant-based formulations.
5. Deep portfolio of products for pain, epilepsy, and eating disorders.
Company is listed on the NYSE American: IGC
It is also available for trading on the open market of Germany: Borse Frankfurt, Berlin and Stuttgart: IGS1
The symbols on Yahoo Finance: IGC, IGS1.F, IGS1.BE, IGS1.SG
We have no warrants outstanding.
We are a Maryland based company located in Bethesda Maryland, USA.
We use Continental Stock Transfer & Trust Company.
To receive a copy of IGC’s annual report, please go to sec.gov.
Our financial year ends on March 31.